English 
Spanish 
TWiV 976 Clinical Update
This Week in Virology Host: Vincent Racaniello Guest: Daniel Griffin Aired 21 January 2023 pdf […]
TWiV 976 Clinical Update Read More »
TWiV 974 Clinical Update
This Week in Virology Host: Vincent Racaniello Guest: Daniel Griffin Aired 14 January 2023 pdf
TWiV 974 Clinical Update Read More »
TWiV 972 Clinical Update
ThisWeek in Virology Host: Vincent Racaniello Guest: Daniel Griffin Aired 07 January 2022 pdf of
TWiV 972 Clinical Update Read More »
TWiV 970 Clinical Update
This Week in Virology Host: Vincent Racaniello Guest: Daniel Griffin Aired 31 December 2022 pdf
TWiV 970 Clinical Update Read More »
TWiV 967 Clinical Update
This Week in Virology Host: Vincent Racaniello Guest: Daniel Griffin Aired 24 December 2022 pdf
TWiV 967 Clinical Update Read More »
February 16, 2023
Intra-Host Evolution Provides for the Continuous Emergence of SARS-CoV-2 Variants | A Randomized Trial Comparing Omicron-Containing Boosters with the Original Covid-19 Vaccine mRNA-1273 | The political polarization of COVID-19 treatments among physicians and laypeople in the United States | Maternal mRNA covid-19 vaccination during pregnancy and delta or omicron infection or hospital admission in infants: test negative design study | SARS-CoV-2 Neutralizing Antibodies After Bivalent vs. Monovalent Booster | The impacts of SARS-CoV-2 vaccine dose separation and targeting on the COVID-19 epidemic in England
February 9, 2023
The Negative Effect of Preexisting Immunity on Influenza Vaccine |
Prior vaccination enhances immune responses during SARS-CoV-2 breakthrough infection with early activation of memory T cells |
Bacillus Calmette-Guérin vaccine for prevention of COVID-19 and other respiratory tract infections in older adults | Relationship between immune response to SARS-CoV2 vaccines and development of breakthrough infection | Early Treatment with Pegylated Interferon Lambda for Covid-19 | Long-term high-dose immunoglobulin successfully treats Long COVID patients with pulmonary, neurologic, and cardiologic symptoms |
Consistency of covid-19 trial preprints with published reports |
Peru confirms H5N1 avian flu in marine mammals | Incidence of Chronic Spontaneous Urticaria |
COVID-19 Mortality and Progress Toward Vaccinating Older Adults
Nonprofits Partner to Bring Listeners Infectious Disease Puscast
Infectious Disease Puscast is co-hosted by Dr. Griffin and Sara Winn Dong, MD, and is released bi-monthly. In each episode, the doctors discuss the newest and most relevant findings in the field of infectious diseases.
Nonprofits Partner to Bring Listeners Infectious Disease Puscast Read More »
February 2, 2023
Information for Persons Who Are Immunocompromised Regarding Prevention and Treatment of SARS-CoV-2 Infection | Severe Fatigue and Persistent Symptoms at Three Months Following SARS-CoV-2 Infections During the Pre-Delta, Delta, and Omicron Time Periods | Reconsideration of Antinucleocapsid IgG Antibody as a Marker of SARS-CoV-2 Infection Postvaccination for Mild COVID-19 Patients | Effectiveness of Bivalent Boosters against Severe Omicron Infection |
Prevalence and Clinical Outcomes of Respiratory Syncytial Virus versus Influenza in Adults | Assessment of COVID-19 as the Underlying Cause of Death Among Children and Young People Aged 0 to 19 Years in the US |
Association of culturable-virus detection and household transmission of SARS-CoV-2 – California and Tennessee, 2020–2022 | Efficacy and safety of antimicrobial stewardship prospective audit and feedback in patients
January 24, 2023
Codetections of Other Respiratory Viruses Among Children Hospitalized With COVID-19 |
Early and Increased Influenza Activity Among Children — Tennessee |
SARS-CoV-2 variant-related abnormalities detected by prenatal MRI | COVID-19 vaccines versus pediatric hospitalization |
Persistent COVID-19 Symptoms at 6 Months After Onset | Effects of Dexamethasone Use on Viral Clearance Among Patients with COVID-19: A Multicenter Cohort Study |
Impact of vaccination on postacute sequelae of SARS CoV-2 infection in patients with rheumatic diseases |
Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant
